Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy

B Chen, H Choi, LJ Hirsch, A Katz, A Legge… - Epilepsy & Behavior, 2017 - Elsevier
Purpose Psychiatric and behavioral side effects (PBSEs) are common, undesirable effects
associated with antiepileptic drug (AED) use. The objective of the study was to compare the …

Psychobehavioural and cognitive adverse events of anti-seizure medications for the treatment of developmental and epileptic encephalopathies

A Strzelczyk, S Schubert-Bast - CNS drugs, 2022 - Springer
The developmental and epileptic encephalopathies encompass a group of rare syndromes
characterised by severe drug-resistant epilepsy with onset in childhood and significant …

[HTML][HTML] Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: a systematic review

BJ Steinhoff, P Klein, H Klitgaard, C Laloyaux… - Epilepsy & Behavior, 2021 - Elsevier
Purpose To understand the currently available post-marketing real-world evidence of the
incidences of and discontinuations due to the BAEs of irritability, anger, and aggression in …

Mechanisms underlying aggressive behavior induced by antiepileptic drugs: focus on topiramate, levetiracetam, and perampanel

CC Hansen, H Ljung, E Brodtkorb… - Behavioural …, 2018 - Wiley Online Library
Antiepileptic drugs (AEDs) are effective against seizures, but their use is often limited by
adverse effects, among them psychiatric and behavioral ones including aggressive behavior …

The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy

F Perversi, C Costa, A Labate, S Lattanzi… - Frontiers in …, 2023 - frontiersin.org
Glutamate is the brain's main excitatory neurotransmitter. Glutamatergic neurons primarily
compose basic neuronal networks, especially in the cortex. An imbalance of excitatory and …

Perampanel in routine clinical use across Europe: pooled, multicenter, observational data

A Rohracher, G Zimmermann, V Villanueva… - …, 2018 - Wiley Online Library
Objective To pool observational data on the routine use of perampanel to obtain information
on real‐world outcomes and data in populations typically underrepresented in clinical trials …

Expanding the treatment landscape for Lennox-Gastaut syndrome: current and future strategies

A Strzelczyk, S Schubert-Bast - CNS drugs, 2021 - Springer
Abstract Lennox-Gastaut syndrome (LGS), a childhood-onset severe developmental and
epileptic encephalopathy (DEE), is an entity that encompasses a heterogenous group of …

Long‐term effectiveness of add‐on perampanel in patients with Lennox–Gastaut syndrome: A multicenter retrospective study

S Matricardi, E Cesaroni, P Bonanni, N Foschi… - …, 2023 - Wiley Online Library
This retrospective study assessed long‐term effectiveness of add‐on perampanel (PER) in
patients with Lennox–Gastaut syndrome (LGS). Outcomes included time to PER failure and …

AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives

C Di Bonaventura, A Labate, M Maschio… - Expert opinion on …, 2017 - Taylor & Francis
ABSTRACT Introduction: The alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
(AMPA) receptors are the major mediators of glutamate-mediated excitatory …

Effectiveness and safety of perampanel monotherapy for focal and generalized tonic‐clonic seizures: experience from a national multicenter registry

R Toledano Delgado, I García‐Morales… - …, 2020 - Wiley Online Library
Objective To assess the effectiveness and tolerability of perampanel (PER) monotherapy in
routine clinical practice for the treatment of focal onset and generalized tonic‐clonic seizures …